Denver Nephrology Research Division — Denver, Colorado

Denver Nephrology Research Division is a clinical research site located in Denver, Colorado, United States 80230-6441.

Crixeo Health Trust Score: 60/100 (FAIR). This profile has not yet been claimed by the site owner.

Denver Nephrology Research Division has participated in 2 clinical trials with 2 currently active.

Therapeutic areas: IgA Nephropathy, Immunoglobulin A Nephropathy, FSGS.

Sponsors: Novartis Pharmaceuticals, Dimerix Bioscience Pty Ltd.

Sponsor Feasibility Report

Trust Score: 60/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Denver Nephrology Research Division?

Denver Nephrology Research Division has a Crixeo Trust Score of 60/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Denver Nephrology Research Division conducted?

Denver Nephrology Research Division has 2 clinical trials on record, with 2 currently active. Their work covers IgA Nephropathy, Immunoglobulin A Nephropathy, FSGS.

Is Denver Nephrology Research Division accredited by Crixeo Health?

Denver Nephrology Research Division has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Denver Nephrology Research Division?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.